Assessment of the startle response to evaluate hyperekplexia, which is linked to glycine receptor function33 and human mutations in ARHGEF924, revealed no significant difference between Gabra2–1 and littermate controls (Supplementary Fig. 8E, F). The gene discussed is GABRA2; the disease is hyperekplexia.